These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 8686047)

  • 1. [Microalbuminuria in rheumatoid arthritis].
    Nordin H; Pedersen LM; Svensson BH; Bliddal H
    Ugeskr Laeger; 1996 May; 158(22):3141-3. PubMed ID: 8686047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microalbuminuria in patients with rheumatoid arthritis.
    Pedersen LM; Nordin H; Svensson B; Bliddal H
    Ann Rheum Dis; 1995 Mar; 54(3):189-92. PubMed ID: 7748016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative evaluation of the efficacy and tolerance of gold and D-penicillamine preparations in patients with rheumatoid arthritis. II. The effect on the morphological indices of rheumatoid synovitis].
    Shekhter AB; Slobodina GA; Krel' AA; Kanevskaia MZ; Chichasova NV
    Revmatologiia (Mosk); 1990; (2):23-9; discussion 29-30. PubMed ID: 1977194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.
    Verstappen SM; van Albada-Kuipers GA; Bijlsma JW; Blaauw AA; Schenk Y; Haanen HC; Jacobs JW;
    Ann Rheum Dis; 2005 Jan; 64(1):38-43. PubMed ID: 15130899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis.
    Schiff MH; Whelton A
    Semin Arthritis Rheum; 2000 Dec; 30(3):196-208. PubMed ID: 11124283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intention-to-treat analysis of 200 patients with rheumatoid arthritis 12 years after random allocation to either sulfasalazine or penicillamine.
    Capell HA; Maiden N; Madhok R; Hampson R; Thomson EA
    J Rheumatol; 1998 Oct; 25(10):1880-6. PubMed ID: 9779839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rheumatoid arthritis in Morocco. Apropos of 404 observations].
    Benamour S; Zeroual B; Fares L; el Kabli H; Bettal S
    Rev Rhum Mal Osteoartic; 1992 Dec; 59(12):801-7. PubMed ID: 1364064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial.
    Hill J; Bird H; Johnson S
    Ann Rheum Dis; 2001 Sep; 60(9):869-75. PubMed ID: 11502614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.
    Nell VP; Machold KP; Eberl G; Stamm TA; Uffmann M; Smolen JS
    Rheumatology (Oxford); 2004 Jul; 43(7):906-14. PubMed ID: 15113999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of risk factors for periodontal disease in patients with rheumatoid arthritis.
    Gleissner C; Willershausen B; Kaesser U; Bolten WW
    Eur J Med Res; 1998 Aug; 3(8):387-92. PubMed ID: 9707521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of combined drug treatment using gold preparations on indices of lipid peroxidation in patients with rheumatoid arthritis].
    Makarchuk OS
    Vrach Delo; 1990 Mar; (3):70-2. PubMed ID: 1973321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of D-penicillamine and methotrexate in the treatment of rheumatoid arthritis in relation to levels of circulating rheumatoid factors of different classes].
    Zborovskiĭ AB; Sivordova LE; Derevianko LI; Zborovskaia IA; Zavodovskiĭ BV
    Ter Arkh; 1999; 71(1):60-3. PubMed ID: 10097305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A method of continuous aurotherapy for rheumatoid arthritis patients under the control of gold excretion].
    Ornat SIa
    Sov Med; 1991; (7):82-3. PubMed ID: 1683012
    [No Abstract]   [Full Text] [Related]  

  • 17. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
    de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
    Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased prolactin response to hypoglycaemia in patients with rheumatoid arthritis: correlation with disease activity.
    Eijsbouts AM; van den Hoogen FH; Laan RF; Sweep CG; Hermus AR; van de Putte LB
    Ann Rheum Dis; 2005 Mar; 64(3):433-7. PubMed ID: 15319231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia.
    Metsios GS; Stavropoulos-Kalinoglou A; Douglas KM; Koutedakis Y; Nevill AM; Panoulas VF; Kita M; Kitas GD
    Rheumatology (Oxford); 2007 Dec; 46(12):1824-7. PubMed ID: 18032540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can gold therapy be used more safely in rheumatoid arthritis? Adverse drug reactions are more likely in patients with nodular disease, independent of HLA-DR3 status.
    Shah P; Griffith SM; Shadforth MF; Fisher J; Dawes PT; Poulton KV; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2004 Oct; 31(10):1903-5. PubMed ID: 15468351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.